跳至主要内容
临床试验/ISRCTN54337309
ISRCTN54337309进行中(未招募)未知

Hospitalization in dialysis care - Investigation of predictive clinical methodology in renal disease and dialysis addressing risk for hospitalization

ytics Health AB0 个研究点目标入组 75 人开始时间: 2018年3月21日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Provision of informed consent prior to any study specific procedures
  • 2. Female or male 18 years of age or older
  • 3. Subjects in dialysis care or subjects in potential of renal dialysis
  • 4. Subject must be able to read and understand informed consent and questionnaires in the provided languages

排除标准

  • The investigator will individually judge criteria for exclusion of any patient

研究者

发起方
ytics Health AB

相似试验

已完成
4 期
The effects of irbesartan and nebivolol on ambulatory blood pressure in patients with intradialytic hypertension.Patients with end-stage renal disease on hemodialysis with intradialytic hypertensionUrological and Genital DiseasesEnd-stage renal disease
ISRCTN13587185Aristotle University of Thessaloniki School of Medicine38
尚未招募
不适用
The effect of pharmacist medicine counselling on treatment goals in renal dialysis patientsEnd Stage Renal DiseaseRenal and Urogenital - Kidney diseasePublic Health - Health service research
ACTRN12613000564752Waikato District Health Board48
招募中
不适用
Trial for the initiation of dialysis patients by EPA for prevention of cardiovascular event in Juntendo University Hospital
JPRN-UMIN000012150Department of Internal Medicine,Juntendo University Faculty of Medicine200
尚未招募
2 期
A study to gain indepth understanding of Quality of Life of patients undergoing Hemodialysis and assess the effect of Family Empowerment program (Hemodialysis guide and Counseling) on Quality of Life, Adherence, Clinical Outcome and Care giver Burde
CTRI/2022/04/041933PARAMESWARI M
进行中(未招募)
1 期
Estudio con pacientes en prediálisis y diálisis renal para evaluar la seguridad, tolerabilidad e inmunogenicidad de la vacuna recombinante contra la hepatitis B fabricada mediante un proceso modificado A Study in Renal Predialysis and Dialysis Patients of the Safety,Tolerability, and Immunogenicity of Recombinant Hepatitis B Vaccine Manufactured with a Modified Process - Estudio en diálisis de la vacuna de la Hepatitis B (recombinante)Hepatitis B
EUCTR2006-003650-20-ESMerck Sharp & Dohme de España, S.A.276